Sham | MI-untreated | MI+spironolactone | |
---|---|---|---|
LV wall motion abnormality (%) | 0 | 50 ± 5* | 50 ± 4* |
LV wall motion score index | 1 ± 0 | 1.95 ± 0.06* | 1.79 ± 0.07* |
LV end-diastolic dimension (mm) | 8.2 ± 0.1 | 11.2 ± 0.2* | 10.8 ± 0.2* |
LV end-systolic dimension (mm) | 3.9 ± 0.1 | 9.5 ± 0.3* | 9.0 ± 0.3* |
LV end-diastolic area (mm2) | 49 ± 1 | 92 ± 3* | 85 ± 3* |
LV end-systolic area (mm2) | 11 ± 1 | 64 ± 4* | 58 ± 4* |
TVc-o (msec) | 103 ± 10 | 119 ± 6 | 121 ± 6 |
RV end-diastolic dimension (mm) | 3.2 ± 0.1 | 3.4 ± 0.1 | 3.3 ± 0.2 |